Pesquisas alternativas:
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
doses liver » does liver (Expandir a Pesquisa), dose liver (Expandir a Pesquisa), doses over (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
live ther » live them (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver other (Expandir a Pesquisa)
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
doses liver » does liver (Expandir a Pesquisa), dose liver (Expandir a Pesquisa), doses over (Expandir a Pesquisa)
liver thle2 » liver three (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
live ther » live them (Expandir a Pesquisa), live rather (Expandir a Pesquisa), liver other (Expandir a Pesquisa)
1
Por Halicki, Priscila C. B., Ferreira, Laís A., De Moura, Kelly C. G., Carneiro, Paula F., Del Rio, Karina P., Carvalho, Tatiane dos S. C., Pinto, Maria do C. F. R., da Silva, Pedro E. A., Ramos, Daniela F.
Publicado no Front Microbiol (2018)
“... of resistant Mycobacterium tuberculosis strains. These barriers reinforcing the need for development of new...”Publicado no Front Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Zhang, Meijuan, Wang, Haiying, Zhao, Jinbing, Chen, Cong, Leak, Rehana K., Xu, Yun, Vosler, Peter, Gao, Yanqin, Zhang, Feng
Publicado em 2013
“... to induce therapeutic hypothermia have been established; however, most of them are not clinically feasible...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
3
“... them into drug-design and -discovery workflows while trying to answer a critical question: are QM-based...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wesnes, Keith A.
Publicado em 2000
“...This paper reviews the value and utility of measuring cognitive function in the development of new...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Artigo
5
Por A. E. Karateyev
Publicado em 2013-12-01
Assuntos:
“...nonsteroidal anti-inflammatory drugs...”Publicado em 2013-12-01
Obter o texto integral
Artigo
6
“... approach “Design of Experiments (DoE)” as applicable to formulation development of microparticles...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Takenaka, Yukinori, Fukumori, Tomoharu, Yoshii, Tadashi, Oka, Natsuo, Inohara, Hidenori, Kim, Hyeong-Reh Choi, Bresalier, Robert S., Raz, Avraham
Publicado em 2004
Assuntos:
“...Cell Growth and Development...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Pomel, Sébastien, Mao, Wei, Ha-Duong, Tâp, Cavé, Christian, Loiseau, Philippe M.
Publicado no Front Cell Infect Microbiol (2019)
“... countries around the world. In order to find new antileishmanial drugs, an original approach consists...”Publicado no Front Cell Infect Microbiol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Yildirim, Oktay, Gottwald, Matthias, Schüler, Peter, Michel, Martin C.
Publicado no Front Pharmacol (2016)
“...Drug development faces the double challenge of increasing costs and increasing pressure on pricing...”Publicado no Front Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Mingote, Susana, Masson, Justine, Gellman, Celia, Thomsen, Gretchen M., Lin, Chyuan-Sheng, Merker, Robert J., Gaisler-Salomon, Inna, Wang, Yvonne, Ernst, Rachel, Hen, René, Rayport, Stephen
Publicado no Front Syst Neurosci (2016)
“...Genetic pharmacotherapy is an early drug development strategy for the identification of novel CNS...”Publicado no Front Syst Neurosci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... are continuously being made across areas, but how does one optimally combine and focus them to maximize...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Song, Chull S., Moses, Harold L., Rosenthal, Alan S., Gelb, Nancy A., Kappas, Attallah
Publicado em 1971
“.... The ultrastructural changes which accompany the induction of ALAS by drugs and chemicals in adult liver also fail...”Publicado em 1971
Obter o texto integral
Obter o texto integral
Artigo
13
“... to an antibiotic are also discussed. Lastly, the methods that have been developed for the identification...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Berry, Sarah L., Hameed, Hamza, Thomason, Anna, Maciej-Hulme, Marissa L., Saif Abou-Akkada, Somaia, Horrocks, Paul, Price, Helen P.
Publicado no PLoS Negl Trop Dis (2018)
“..., and resistance to them is emerging. New therapeutics are urgently needed, however, screening the infective...”Publicado no PLoS Negl Trop Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Phansalkar, Shobha, Desai, Amrita A, Bell, Douglas, Yoshida, Eileen, Doole, John, Czochanski, Melissa, Middleton, Blackford, Bates, David W
Publicado em 2012
“...OBJECTIVE: To develop a set of high-severity, clinically significant drug–drug interactions (DDIs...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Hoffman, G S
Publicado em 2011
“... the disease, plus vulnerabilities of the patient that prepare them to develop an illness phenotype. Improved...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
18
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Blaine Stothard
Publicado em 2021-11-01
Assuntos:
“...drug policy and control...”Publicado em 2021-11-01
Obter o texto integral
Artigo
20
“... years and 65 years and older, and between those treated with a low and a high dose of each drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo